Over the past 10 years, Nycomed has compiled an impressive track record in research in Canada. As of June 2008, the company has been involved with more than 50 clinical trials, enrolling almost 10,000 patients. At present, three clinical studies at various stages are ongoing, involving more than 240 physicians and including over 1,300 patients across Canada.
Nycomed actively supports the objective of discovering new medicines that improve the quality of health care for every Canadian.
ALVESCO® is the brand name for the medication ciclesonide inhalation aerosol.
(PDF format)
OMNARIS™ is the brand name for the medication ciclesonide nasal spray.
(PDF format)
PANTOLOC® is the brand name for the medication pantoprazole sodium.
(PDF format)
Pantoprazole sodium also comes in an intravenous formulation known as PANTO®IV
(PDF format)
TECTA™ is the brand name for the medication pantoprazole magnesium.
View TECTA™ product monograph
(PDF Format)
®Registered trademark of Nycomed GmbH. Used under license.
™Trademark of Nycomed GmbH. Used under license.
RESULTZ® is a treatment for head lice.
(PDF format)
® Registered Trademark of Nycomed Canada Inc.
Visit beatheadlice.ca
Partnerships Products:
POLLINEX®-R is the brand name for the medication modified ragweed tyrosine adsorbate vaccine.
View POLLINEX®-R product monograph
(PDF Format)
® Registered Trademark of Allergy Therapeutics (UK) Ltd
TRIDURAL™ is the brand name for the medication tramadol hydrochloride.
View TRIDURAL™ product monograph
(PDF Format)
™ Trademark of Labopharm Inc.